Precision Medicine Market - Global Industry Analysis

Precision Medicine Market

Precision Medicine Market Size, Share, Trends, Growth, Analysis, Forecast to 2028

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3876 Published Date: Aug-2019 Status : Published

Table Of Content

Methodology

Free Analysis

Precision medication (PM) is a form of medication that uses data about a person’s genes, proteins, lifestyle, and environment to forestall, diagnose, and treat diseases. It is an emerging approach that proposes the customization of aid with medical alternatives, treatments, practices, or merchandise that are being tailored for an individual patient.

Modern developments in applications of big data technologies for the correct detection of diseases are driving the precision drugs market. In addition, important company players are concentrating their efforts on improving software systems that support drug discovery procedures, which, in turn, helps in storing huge amounts of genetic information, thereby supporting the medicine precision market. However, deviation from treatment-based to preventive healthcare, abstaining trends in food and drug administration pharmacotherapy approval rate, the encroachment of privacy rules, and misconception of genetic and health data may limit the precision medicine market growth.

Global Precision Medicine Market

The global precision medicine market is classified based on technology, application, and end-user. By technology, the market is divided into drug discovery, big data analytics, bioinformatics, companion diagnostics, genomic sequencing, and others. The drug discovery segment holds the largest market share, of about 25%, which is closely followed by companion diagnostics and genomic sequencing. Based on application, the market includes respiratory, oncology, CNS, immunology, and others. Oncology is likely to witness the highest CAGR in the market over the forecast timeframe. Immunology accounted for the second-largest market share in 2018 and is anticipated to indicate similar growth trends over the forthcoming years. By end-user, the market includes pharmacy and biotechnology firms, diagnostic companies, healthcare-IT/big data firms, clinical laboratories, and others. Healthcare-IT/big data firms are predicted to hold a substantial share in the precision medicine market over the estimated timeframe.

North America is likely to account for the most important share of the precision medicine market over the forecast timeframe, owing to the increasing geriatric population suffering from chronic diseases like cancer, cardiovascular diseases, diabetes, etc. The Asia Pacific precision medicine market is projected to grow notably in the future, owing to the rising burden of genetic diseases in China that will drive the demand for gene therapies. Government of China has taken initiatives to fund the Chinese precision medicine market growth, which will advance the Asia Pacific precision medicine market growth in the future.

Some major players of the precision medicine market are Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed